|
||||||||||||||||
HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
CHI's MICROARRAY DATA ANALYSIS | ||||||||||||||||
September 21, 2001 | ||||||||||||||||
Cambridge Healthtech Institute, New Hotel: Hilton Alexandria Mark Center, Alexandria, Virginia New Dates: November 12-13, 2001 New Dates: November 12-13, 2001 Workshop, Mining for Gold: November 14, 2001 Microarrays have exploded in the field of biological research. In fact, over 80 percent of laboratories using microarrays expect to increase their utilization over the next year. However, with the "boom" of the technology also comes the need for careful navigation through interpretation of the data minefield. The facilitation of adoption of standards for microarray experimental annotation, data representation, and the introduction of standard experimental controls and data normalization is critical for the resulting "boom" to be either destructive or productive. |
||||||||||||||||
Organized by: | Cambridge Healthtech Institute | |||||||||||||||
Invited Speakers: | Scientific Advisors Mr. Thomas J. Downey, Partek Incorporated Dr. Nathan Goodman, 3rd Millennium, Inc. Dr. Hrissi Samartzidou, Molecular Dynamics/Amersham Pharmacia Biotech Speakers Dr. Dhammika Amaratunga, The R.W. Johnson Pharmaceutical Research Institute Dr. Tarif A. Awad, Affymetrix, Inc. Dr. Alex Chenchik, BD Clontech Laboratories, Inc. Dr. Gary A. Churchill, The Jackson Laboratory Mr. Thomas J. Downey, Partek Incorporated Dr. Sorin Draghici, Wayne State University Dr. Mary E. Edgerton, Vanderbilt University Medical Center Dr. Michael Elashoff, Gene Logic, Inc. Dr. James T. Fleming, University of Tennessee Mr. Jason Goncalves, Iobion Informatics Dr. Steven R. Gullans, Harvard Institutes of Medicine Dr. Priti Hegde, GlaxoSmithKline Pharmaceuticals Dr. Thomas M. Houts, Molecular Dynamics Dr. Reid M. Huber, DuPont Pharmaceuticals Dr. Simon M. Lin, Duke University Medical Center Dr. Robert Nadon, Imaging Research Inc. Dr. Steven Perrin, Biogen, Inc. Dr. Michael Reich, The Whitehead Institute Dr. David Robbins, ViaLogy Dr. Hrissi Samartzidou, Molecular Dynamics/Amersham Pharmacia Biotech Dr. Ed Spitznagel, Washington University Dr. Chris Stoeckert, University of Pennsylvania Dr. Greg Tucker-Kellogg, Millennium Pharmaceuticals Dr. Joseph White, The Institute for Genomic Research |
|||||||||||||||
Deadline for Abstracts: | N/A | |||||||||||||||
Registration: | http://www.chidb.com/2001/mda/index.htm | |||||||||||||||
E-mail: | fvargus@healthtech.com | |||||||||||||||
Posted by: | Frederick Vargus | |||||||||||||||
Host: | wks253.healthtech.com | |||||||||||||||
|
||||||||||||||||
Generated by meetings and positions 5.0 by Kai Garlipp |